Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Retirement planning is essential for achieving financial stability in your later years. Learn why it's never too early to start planning.
21,478 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As lawmakers push hundreds of AI bills, a lack of universal testing leaves companies and investors facing a maze of r...
A new Seattle class-action accuses Amazon of retaining hundreds of millions in tariff revenue by raising consumer pri...
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Some stocks look expensive at first glance, but the real value lies beneath the surface. Learn how to spot stocks tha...
A Minnesota nonprofit leader was sentenced to nearly 42 years for orchestrating a $250 million fraud tied to pandemic...
When a major institutional investor trims a fund like COMT, the move can ripple through risk, liquidity, and prices. ...
Nvidia is expanding beyond chips by taking stakes in fellow AI players. This strategic move could quietly power growt...
As Costco prepares to report Q4 results, investors weigh whether costco wholesale corp's stock deserves a spot in the...
A major hedge fund exit grabbed headlines as a fund controlled by William Oberndorf liquidated a sizable monday.com s...
Celsius founder Alex Mashinsky has filed to vacate a 12-year crypto fraud sentence, signaling a dramatic turn in a ca...
Dell Technologies has moved from the shadows into the AI spotlight. This guide explains why the stock is drawing atte...